Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and nine months ended December 31, 2025.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has shared the audio recording of its earnings conference call covering the quarter and nine months ended December 31, 2025. This is a procedural disclosure where the company uploads the call recording to the exchange portal, typically within a few days of the call. The actual discussion content (management commentary, guidance, Q&A) is not included in this filing itself — investors would need to listen to the recording for details.
No direct impact on stock price. The recording may contain management commentary on results and outlook that could influence investor sentiment once heard.